56 related articles for article (PubMed ID: 38438999)
1. Resistance training modifies of serum levels of matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases in multiple sclerosis women - a randomized controlled trail.
Nezhad NN; Parnow A; Khamoushian K; Eslami R; Baker JS
BMC Neurosci; 2024 Mar; 25(1):13. PubMed ID: 38438999
[TBL] [Abstract][Full Text] [Related]
2. Exercise training reduces systemic inflammation and improves general health status in female migraineurs: a randomised controlled trail.
Pairo Z; Parnow A; Sari Aslani P; Mohammadi P; Mirzaeei S; Mohr M
Eur J Appl Physiol; 2024 May; 124(5):1397-1408. PubMed ID: 38043087
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
[TBL] [Abstract][Full Text] [Related]
5. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment.
Avolio C; Filippi M; Tortorella C; Rocca MA; Ruggieri M; Agosta F; Tomassini V; Pozzilli C; Stecchi S; Giaquinto P; Livrea P; Trojano M
Mult Scler; 2005 Aug; 11(4):441-6. PubMed ID: 16042227
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and antioxidant effects of docosahexaenoic acid (DHA) in an experimental model of multiple sclerosis.
Muñoz-Jurado A; Escribano BM; Galván A; Valdelvira ME; Caballero-Villarraso J; Giraldo AI; Santamaría A; Luque E; Agüera E; LaTorre M; Túnez I
J Nutr Biochem; 2024 Feb; 124():109497. PubMed ID: 37875228
[TBL] [Abstract][Full Text] [Related]
8. IL-6 and TNF-α responses to acute and regular exercise in adult individuals with multiple sclerosis (MS): a systematic review and meta-analysis.
Shobeiri P; Seyedmirzaei H; Karimi N; Rashidi F; Teixeira AL; Brand S; Sadeghi-Bahmani D; Rezaei N
Eur J Med Res; 2022 Sep; 27(1):185. PubMed ID: 36156182
[TBL] [Abstract][Full Text] [Related]
9. Aerobic training improves blood-brain barrier and neuronal apoptosis in experimental autoimmune encephalomyelitis.
Razi O; Parnow A; Rashidi I; Pakravan N; Nedaei SE; Motl RW
Iran J Basic Med Sci; 2022 Feb; 25(2):245-253. PubMed ID: 35655596
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies.
Futtrup J; Margolinsky R; Benros ME; Moos T; Routhe LJ; Rungby J; Krogh J
Brain Behav Immun Health; 2020 Jul; 6():100102. PubMed ID: 34589864
[TBL] [Abstract][Full Text] [Related]
11. Effective rehabilitation interventions and participation among people with multiple sclerosis: An overview of reviews.
Momsen AH; Ørtenblad L; Maribo T
Ann Phys Rehabil Med; 2022 Jan; 65(1):101529. PubMed ID: 33940247
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their tissue inhibitors in relapsing remitting multiple sclerosis: Possible markers and treatment agents.
Sanli A; Ozturk M; Soysal A; Doventas Y; Basoglu F; Gozubatik-Celik GR; Baybas S
Ideggyogy Sz; 2021 Jan; 74(1-2):50-56. PubMed ID: 33497055
[TBL] [Abstract][Full Text] [Related]
13. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
